William Parker Group

07/04/2022

Regenerative medicine couldn't stop making news in 2021!

Regenerative medicine couldn't stop making news in 2021. | Regenerative medicine couldn't stop making news in 2021. The year was marked by Intellia's first results in humans for gene editing, massive Big Pharma partnerships and record investment.

06/04/2022

The tide is starting to turn in pancreatic cancer, finally bringing the kind of advances that have been seen in other types of cancers to this difficult-to-treat condition.

Speakers at the 2022 Virtual Growth Conference’s session on pancreatic cancer acknowledged the exceptional challenges while extolling advances in immune-based therapies and combination approaches.

07/02/2022

04/02/2022

Create a future without cancer

26/01/2022

Altos Labs just redefined big in biotech. Where to start? The $3 billion in investor support? The C-suite staffed by storied leaders!

Altos Labs just redefined big in biotech. Where to start? The $3 billion in investor support? The C-suite staffed by storied leaders—Barron, Bishop, Klausner—identifiable by one name? Or the wildly ambitious plan to reverse disease for patients of any age? Altos is all that and more.

25/01/2022

ImmunityBio today shared interim results from its ongoing metastatic pancreatic cancer trial, demonstrating overall survival that's double the historical rate.

According to preliminary results, the OS for patients doubled against the current historical rate of three months after receiving two therapy lines.

25/01/2022

24/01/2022

Great opportunity with a world-class pharmaceutical service Company